Histone H3 phosphorylation in GBM: a new rational to guide the use of kinase inhibitors in anti-GBM therapy.
about
Global histone post-translational modifications and cancer: Biomarkers for diagnosis, prognosis and treatment?Cross talk of tyrosine kinases with the DNA damage signaling pathwaysp38-MAPK/MSK1-mediated overexpression of histone H3 serine 10 phosphorylation defines distance-dependent prognostic value of negative resection margin in gastric cancer.Targeting dual specificity protein kinase TTK attenuates tumorigenesis of glioblastoma.
P2860
Histone H3 phosphorylation in GBM: a new rational to guide the use of kinase inhibitors in anti-GBM therapy.
description
2015 nî lūn-bûn
@nan
2015 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Histone H3 phosphorylation in ...... nhibitors in anti-GBM therapy.
@ast
Histone H3 phosphorylation in ...... nhibitors in anti-GBM therapy.
@en
Histone H3 phosphorylation in ...... nhibitors in anti-GBM therapy.
@nl
type
label
Histone H3 phosphorylation in ...... nhibitors in anti-GBM therapy.
@ast
Histone H3 phosphorylation in ...... nhibitors in anti-GBM therapy.
@en
Histone H3 phosphorylation in ...... nhibitors in anti-GBM therapy.
@nl
prefLabel
Histone H3 phosphorylation in ...... nhibitors in anti-GBM therapy.
@ast
Histone H3 phosphorylation in ...... nhibitors in anti-GBM therapy.
@en
Histone H3 phosphorylation in ...... nhibitors in anti-GBM therapy.
@nl
P2093
P2860
P356
P1433
P1476
Histone H3 phosphorylation in ...... inhibitors in anti-GBM therapy
@en
P2093
Arulraj Nadaradjane
François M Vallette
Mathilde Cheray
Romain Pacaud
P2860
P356
10.7150/THNO.8799
P577
2015-01-01T00:00:00Z